In particular, it suppressed Ki67+CD8+, TNFα+CD8+, and IFNγ+CD8+ T cells while restoring PD‐1+CD8+ and TIM‐3+CD8+ T cells in tumor lesions (Figure 6I–M). This evidence concerns the gene HAVCR2 and neoplasm.